Spots Global Cancer Trial Database for mgmt
Every month we try and update this database with for mgmt cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma | NCT05739942 | Newly Diagnosed... | [177Lu]Lu-NeoB [68Ga]Ga-NeoB Temozolomide | 18 Years - | Novartis | |
| Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma | NCT05739942 | Newly Diagnosed... | [177Lu]Lu-NeoB [68Ga]Ga-NeoB Temozolomide | 18 Years - | Novartis | |
| 5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer. | NCT04689347 | Metastatic Colo... | Bevacizumab Irinotecan Leucovorin 5Fluorouracil Temozolomide | 18 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Preoperative CRT With Capecitabine ± Temozolomide in Patients With LARC | NCT03156036 | Advanced Rectal... | Capecitabine pl... | 20 Years - | Asan Medical Center | |
| A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent. | NCT05109728 | Glioblastoma | [177Lu]Lu-DOTA-... [68Ga]Ga-DOTA-T... Temozolomide Radiotherapy | 18 Years - | Novartis | |
| Temozolomide and Irinotecan in Patients With MGMT Silenced Colorectal Cancer After Adjuvant Chemotherapy | NCT05031975 | Colorectal Canc... | Irinotecan Temozolomide | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Serum DNA Analysis: Potential Application for Diagnosis and Prognosis in Brain Cancer. | NCT00265174 | Primary Brain T... | - | Hadassah Medical Organization | ||
| Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma | NCT02928575 | Glioblastoma Mu... | Sunitinib Temozolomide Radiation Thera... | 18 Years - 70 Years | McGill University Health Centre/Research Institute of the McGill University Health Centre | |
| NIVOLUMAB Plus IPILIMUMAB and TEMOZOLOMIDE in Microsatellite Stable, MGMT Silenced Metastatic Colorectal Cancer | NCT03832621 | Metastatic Colo... | Temozolomide Nivolumab Ipilimumab | 18 Years - 99 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Preoperative CRT With Capecitabine ± Temozolomide in Patients With LARC | NCT03156036 | Advanced Rectal... | Capecitabine pl... | 20 Years - | Asan Medical Center | |
| Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal Cancer | NCT05136326 | Rectal Cancer | External-beam r... Capecitabine Temozolomide | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal Cancer | NCT05136326 | Rectal Cancer | External-beam r... Capecitabine Temozolomide | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma | NCT02928575 | Glioblastoma Mu... | Sunitinib Temozolomide Radiation Thera... | 18 Years - 70 Years | McGill University Health Centre/Research Institute of the McGill University Health Centre | |
| Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma | NCT02928575 | Glioblastoma Mu... | Sunitinib Temozolomide Radiation Thera... | 18 Years - 70 Years | McGill University Health Centre/Research Institute of the McGill University Health Centre | |
| Temozolomide and Irinotecan in Patients With MGMT Silenced Colorectal Cancer After Adjuvant Chemotherapy | NCT05031975 | Colorectal Canc... | Irinotecan Temozolomide | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent. | NCT05109728 | Glioblastoma | [177Lu]Lu-DOTA-... [68Ga]Ga-DOTA-T... Temozolomide Radiotherapy | 18 Years - | Novartis |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
